Results 71 to 80 of about 1,423 (137)

HD6277 Suppresses Muscle Atrophy by Promoting Myogenic Factors and Inhibiting Proteolysis in Aged Mice

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background G protein–coupled receptor 40 (GPR40) acts as a modulator of various physiological functions, including glycaemic lowering, anti‐inflammation and antioxidative stress, in several tissues. However, the role of GPR40 in skeletal muscles remains unclear.
Joo Won Kim   +9 more
wiley   +1 more source

Improved Chemistry of myo‐Inositol: A New Synthetic Strategy to Protected 1‐Keto‐ and 1,2‐Keto‐Inososes

open access: yesEuropean Journal of Organic Chemistry, Volume 28, Issue 11, March 17, 2025.
A refresh of the well‐known myo‐inositol chemistry is reported with a special focus on 2‐O‐alkylated compounds, chiro‐1‐inosose, 1,2‐diketone and 3‐deoxy‐1,2‐diketone derivatives optimizing the synthetic protocol also in gram scale. Orthogonally protected chiro‐1‐inosose was transformed into cyanohydrins to access to poly‐hydroxylated‐(aminomethyl ...
Francesco Anastasi   +7 more
wiley   +1 more source

Comparing Myo-Inositol and Folic Acid with and without D-Chiro-Inositol for The Management of Polycystic Ovary Syndrome

open access: yesPakistan Journal of Medicine and Dentistry
Background: Polycystic ovarian syndrome (PCOS) is an endocrinological disease of women of the reproductive age group. The study aimed to compare the efficacy of Myo-inositol and folic acid with and without D-chiro-inositol in the improvement of symptoms
Reja Akram   +4 more
doaj   +1 more source

New prospects of the integrative therapy for polycystic ovary syndrome in women with the disorders of carbohydrate and lipid metabolism: a comparative study. [PDF]

open access: yesРМЖ. Мать и дитя, 2020
Yu.E. Dobrokhotova, I.A. Lapina, T.G. Chirvon, V.V. Taranov Pirogov Russian National Research Medical University, Moscow, Russian Federation Background: long-term combined estrogen-progestin oral contraceptive pills (COCPs)
Yu.E. Dobrokhotova   +3 more
doaj  

The role of inositol in improving fertility in patients with PCOS

open access: yesJournal of Education, Health and Sport
Introduction and purpose Polycystic ovary syndrome is a common reproductive disorder, accompanied primarily by hyperandrogenism and insulin resistance. Myo-inositol (MI) and D-chiro-inositol (DCI), have emerged as potential therapeutic agents due to
Kamila Turek   +9 more
doaj   +1 more source

Inositols in Insulin Signaling and Glucose Metabolism

open access: yesInternational Journal of Endocrinology, 2018
In the past decades, both the importance of inositol for human health and the complex interaction between glucose and inositol have been the subject of increasing consideration. Glucose has been shown to interfere with cellular transmembrane transport of
Arturo Bevilacqua, Mariano Bizzarri
doaj   +1 more source

Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

open access: yesGynecological Endocrinology
In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of ...
Iñaki Lete   +4 more
doaj   +1 more source

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome. [PDF]

open access: yesFront Pharmacol, 2022
Yang H   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy